1. Ak G et al (2021) An intravenous application of magnetic nanoparticles for osteomyelitis treatment: an efficient alternative. Int J Pharm 592:119999. https://doi.org/10.1016/j.ijpharm.2020.119999
2. Alruwaili NK, Rizwanullah M, Imam SS, Afzal M, Alharbi KS, Ahmad J (2021) Fundamental aspects of targeted drug delivery. In: Mehra NK, Jain K (eds) Dendrimers in nanomedicine, 1st edn. CRC Press, Boca Raton, pp 19–39
3. Bae YH, Park K (2011) Targeted drug delivery to tumors: myths, reality and possibility. J Control Release 153(3):198–205. https://doi.org/10.1016/j.jconrel.2011.06.001
4. Balakrishnan B et al (2020) Multifunctional core–shell glyconanoparticles for galectin-3-targeted, trigger-responsive combination chemotherapy. Biomacromolecules 21(7):2645–2660. https://doi.org/10.1021/acs.biomac.0c00358
5. Barrientos AG, de la Fuente JM, Rojas TC, Fernandez A, Penades S (2003) Gold glyconanoparticles: synthetic polyvalent ligands mimicking glycocalyx-like surfaces as tools for glycobiological studies. Chemistry 9(9):1909–1921. https://doi.org/10.1002/chem.200204544